• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Integra, Dr. Reddy’s ink deal for DuraGen in India

March 27, 2017 By Sarah Faulkner

Integra, Dr. Reddy's ink deal for DuraGen in IndiaIntegra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India.

The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of dura mater in patients undergoing cranial and spinal procedures. The matrix protects against cerebro-spinal fluid leakage and is fully resorbed and replaced by native tissue, the companies said.

“We are delighted to partner with Integra LifeSciences. With the launch of DuraGen, we look forward to building our presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery,” Dr. Reddy’s executive VP & head of emerging markets and India biz M.V. Ramana said in prepared remarks.

“Our market-leading DuraGen products have helped more than 1 million patients worldwide,” Integra LifeSciences CFO and corporate VP of international biz Glenn Coleman added. “This collaboration will allow us to continue to expand patient access globally and provide innovative regenerative technology solutions to neurosurgeons and patients in India.”

The suturable DuraGen matrix is a graft that can be sutured and was designed to repair dural defects in patients who require mechanical anchoring of the graft.

Integra said its DuraGen products have been used in more than 1.8 million patients to facilitate dural closure following neurosurgical operations.

Filed Under: Featured, Implants, Surgical, Wound Care Tagged With: Dr. Reddy's Laboratories, Integra LifeSciences

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS